In the dynamic landscape of modern healthcare and precision medicine,the digital revolution is reshaping medical industries at an unprecedented pace,and traditional Chinese medicine(TCM)is no exception[1-4].The paper...In the dynamic landscape of modern healthcare and precision medicine,the digital revolution is reshaping medical industries at an unprecedented pace,and traditional Chinese medicine(TCM)is no exception[1-4].The paper“From digits towards digitization:the past,present,and future of traditional Chinese medicine”by Academician&TCM National Master Qi WANG(王琦).展开更多
In the era of precision medicine,the breast cancer surgical treatment field is gradually moving toward a de-escalation model.Through precise preoperative assessments and multidisciplinary decision-making,surgical trau...In the era of precision medicine,the breast cancer surgical treatment field is gradually moving toward a de-escalation model.Through precise preoperative assessments and multidisciplinary decision-making,surgical trauma can be decreased,and patients’quality of life can be improved by ensuring safety.Herein,we explore the axillary de-escalation surgery model for breast cancer.展开更多
Lynch syndrome(LS)is the most common hereditary colorectal cancer(CRC)predisposition syndrome,characterized by a high mutational burden and microsatellite instability-high(MSI-H)tumors.Immunology of LS-associated CRC(...Lynch syndrome(LS)is the most common hereditary colorectal cancer(CRC)predisposition syndrome,characterized by a high mutational burden and microsatellite instability-high(MSI-H)tumors.Immunology of LS-associated CRC(LS-CRC)is unique,with significant implications for treatment.Despite well-established knowledge of LS immunology,immunotherapy dose and treatment response can vary significantly based on local tumor immunity and specific germline pathogenic variant of LS genes.This variability necessitates tailored surveillance strategies and new personalised immunotherapy approaches for LS patients.LS-CRC often benefits from immunotherapy due to the distinct tumor microenvironment(TME)and the variety of tumor infiltrating lymphocytes(TILs).This perspective discusses a novel approach of analysing spatial TILs at a single-cell level using tumor whole slide images(WSIs)that accounts for the distinct TME of LS-CRC.By emphasizing the necessity of personalized medicine in hereditary cancer syndromes,the future research and clinical practices that enhance patient outcomes through precision oncology is inspired.展开更多
The management of breast cancer,one of the most common and heterogeneous malignancies,has transformed with the advent of precision medicine.This review explores current developments in genetic profiling,molecular diag...The management of breast cancer,one of the most common and heterogeneous malignancies,has transformed with the advent of precision medicine.This review explores current developments in genetic profiling,molecular diagnostics,and targeted therapies that have revolutionized breast cancer treatment.Key innovations,such as cyclin-dependent kinases 4/6(CDK4/6)inhibitors,antibodydrug conjugates(ADCs),and immune checkpoint inhibitors(ICIs),have improved outcomes for hormone receptor-positive(HR+),HER2-positive(HER2+),and triple-negative breast cancer(TNBC)subtypes remarkably.Additionally,emerging treatments,such as PI3K inhibitors,poly(ADP-ribose)polymerase(PARP)inhibitors,and m RNA-based therapies,offer new avenues for targeting specific genetic mutations and improving treatment response,particularly in difficult-to-treat breast cancer subtypes.The integration of liquid biopsy technologies provides a non-invasive approach for real-time monitoring of tumor evolution and treatment response,thus enabling dynamic adjustments to therapy.Molecular imaging and artificial intelligence(AI)are increasingly crucial in enhancing diagnostic precision,personalizing treatment plans,and predicting therapeutic outcomes.As precision medicine continues to evolve,it has the potential to significantly improve survival rates,decrease recurrence,and enhance quality of life for patients with breast cancer.By combining cutting-edge diagnostics,personalized therapies,and emerging treatments,precision medicine can transform breast cancer care by offering more effective,individualized,and less invasive treatment options.展开更多
Artificial intelligence(AI)is driving a paradigm shift in gastroenterology and hepa-tology by delivering cutting-edge tools for disease screening,diagnosis,treatment,and prognostic management.Through deep learning,rad...Artificial intelligence(AI)is driving a paradigm shift in gastroenterology and hepa-tology by delivering cutting-edge tools for disease screening,diagnosis,treatment,and prognostic management.Through deep learning,radiomics,and multimodal data integration,AI has achieved diagnostic parity with expert cli-nicians in endoscopic image analysis(e.g.,early gastric cancer detection,colorectal polyp identification)and non-invasive assessment of liver pathologies(e.g.,fibrosis staging,fatty liver typing)while demonstrating utility in personalized care scenarios such as predicting hepatocellular carcinoma recurrence and opti-mizing inflammatory bowel disease treatment responses.Despite these advance-ments challenges persist including limited model generalization due to frag-mented datasets,algorithmic limitations in rare conditions(e.g.,pediatric liver diseases)caused by insufficient training data,and unresolved ethical issues related to bias,accountability,and patient privacy.Mitigation strategies involve constructing standardized multicenter databases,validating AI tools through prospective trials,leveraging federated learning to address data scarcity,and de-veloping interpretable systems(e.g.,attention heatmap visualization)to enhance clinical trust.Integrating generative AI,digital twin technologies,and establishing unified ethical/regulatory frameworks will accelerate AI adoption in primary care and foster equitable healthcare access while interdisciplinary collaboration and evidence-based implementation remain critical for realizing AI’s potential to redefine precision care for digestive disorders,improve global health outcomes,and reshape healthcare equity.展开更多
The gears of new energy vehicles are required to withstand higher rotational speeds and greater loads,which puts forward higher precision essentials for gear manufacturing.However,machining process parameters can caus...The gears of new energy vehicles are required to withstand higher rotational speeds and greater loads,which puts forward higher precision essentials for gear manufacturing.However,machining process parameters can cause changes in cutting force/heat,resulting in affecting gear machining precision.Therefore,this paper studies the effect of different process parameters on gear machining precision.A multi-objective optimization model is established for the relationship between process parameters and tooth surface deviations,tooth profile deviations,and tooth lead deviations through the cutting speed,feed rate,and cutting depth of the worm wheel gear grinding machine.The response surface method(RSM)is used for experimental design,and the corresponding experimental results and optimal process parameters are obtained.Subsequently,gray relational analysis-principal component analysis(GRA-PCA),particle swarm optimization(PSO),and genetic algorithm-particle swarm optimization(GA-PSO)methods are used to analyze the experimental results and obtain different optimal process parameters.The results show that optimal process parameters obtained by the GRA-PCA,PSO,and GA-PSO methods improve the gear machining precision.Moreover,the gear machining precision obtained by GA-PSO is superior to other methods.展开更多
Approximately 2.5%of the global population experience allergic reactions to seafood,making it one of the most prevalent and life-threatening allergies.Seafood allergy can lead to the disruption of the intestinal barri...Approximately 2.5%of the global population experience allergic reactions to seafood,making it one of the most prevalent and life-threatening allergies.Seafood allergy can lead to the disruption of the intestinal barrier,possibly due to aberrant intestinal glycosylation.In this study,the mechanisms underlying seafood allergy were explored through the lens of intestinal glycobiology.Mice were sensitized with tropomyosin,resulting in significant increases in allergy symptom scores,specific antibody and T helper 2 cytokine levels.Intestinal damage was confirmed by histopathology,as well as by assessments and levels of diamine oxidase and claudin-1.Moreover,alterations in glycosylated proteins within the jejunum were analyzed using highthroughput mass spectrometry and the pGlyco3.0 search engine.Precision N-glycoproteomics analysis yielded 2283 glycosylation peptides corresponding to 655 unique glycosylation sites on 399 proteins.Differential expression and enrichment analyses revealed that differentially expressed glycoproteins were significantly enriched in the extracellular matrix(ECM)-receptor interaction pathway and focal adhesion pathway.In conclusion,tropomyosin sensitization leads to intestinal glycome changes,accompanied by remodeling of the intestinal ECM.Our research establishes an essential theoretical basis for targeting the intestinal glycome and ECM remodeling in a precise and fine-tuned manner for the treatment of food allergies.展开更多
Background:Precision medicine(PM)has taken center stage in healthcare since the completion of the genomic project.Developed countries have gradually integrated PM into mainstream patient management.However,Nigeria sti...Background:Precision medicine(PM)has taken center stage in healthcare since the completion of the genomic project.Developed countries have gradually integrated PM into mainstream patient management.However,Nigeria still grapples with wide acceptance,key translational research and implementation of PM.This study sought to explore the knowledge and attitude of PM among pharmacists as key stakeholders in the healthcare team.Methods:A cross‐sectional study was conducted in selected tertiary hospitals across the country.A 21‐item semi‐structured questionnaire was administered by hybrid online and physical methods and the results analyzed with Statistical Package for the Social Sciences Version 25.Descriptive statistics were used to summarize the data.A chi‐square test was employed to determine the association of knowledge of PM and the sociodemographic characteristics of the study population.Results:A total of 167 hospital pharmacists participated in the study.A high proportion of the participants are familiar with artificial intelligence(91.75%),Pharmacogenomics(84.5%),and precision medicine(61%).Overall,38.9%of the pharmacists had a good knowledge while 13.2%had a poor knowledge of PM and associated terms.The level of knowledge did not correlate significantly with gender(X^(2)=3.21,p=0.201),age(X^(2)=5,p=0.27),marital status(X^(2)=3.21,p=0.201),and professional level(X^(2)=6.85,p=0.144).The most important value of precision medicine to hospital pharmacists is the ability to minimize the impact of disease through preventive medicine(49%)while a large portion are pursuing and or actively planning to pursue additional education in precision medicine.Conclusions:There is a highly positive attitude toward the prospect of PM among hospital pharmacists in Nigeria.Education modules in this field are highly recommended as most do not have a holistic knowledge of terms used in PM.Also,more research aimed at translating PM knowledge into clinical practice is recommended.展开更多
Pancreatic ductal adenocarcinoma(PDAC)is a global health challenge and remains one of the most lethal malignancies;there are only a few therapeutic options.However,significant efforts have led to the identification of...Pancreatic ductal adenocarcinoma(PDAC)is a global health challenge and remains one of the most lethal malignancies;there are only a few therapeutic options.However,significant efforts have led to the identification of major genetic factors that drive the progression and pathogenesis of PDAC.Notably,the research and application of molecular targeted therapies and immunotherapies have rapidly increased and facilitated great progress in the treatment of many malignant tumors,additional targeted therapies and immunotherapy based on next-generation sequencing results provide new opportunities for the diagnosis and treatment of pancreatic tumors.Immune checkpoint inhibitors are also now being incorporated as PDAC therapies,and combinations of molecularly targeted therapies with immunotherapies are emerging as strategies for boosting the immune response.The investigation of biomarkers of a response or primary resistance to immunotherapies is also an emerging research area.Herein,we further discuss the recent technological advances that continue to expand our understanding of PDAC complexity.We discuss the advancements expected in the near future,including biomarker-driven treatments and immunotherapies.We presume that the clinical translation of these research efforts will improve the survival outcomes of this challenging disease,which are currently dismal.展开更多
Micro-grinding has been widely used in aerospace and other industry.However,the small diameter of the micro-grinding tool has limited its machining performance and efficiency.In order to solve the above problems,micro...Micro-grinding has been widely used in aerospace and other industry.However,the small diameter of the micro-grinding tool has limited its machining performance and efficiency.In order to solve the above problems,micro-structure has been applied on the micro-grinding tool.A morphology modeling has been established in this study to characterize the surface of microstructured micro-grinding tool,and the grinding performance of micro-structured micro-grinding tool has been analyzed through undeformed chip thickness,abrasive edge width,and effective distance between abrasives.Then deviation analysis,path optimization and parameter optimization of microchannel array precision grinding have been finished to improve processing quality and efficiency,and the deflection angle has the most obvious effects on the rectangular slot depth,micro-structured micro-grinding tool could reduce 10%surface roughness and 20%grinding force compared to original micro-grinding tool.Finally,the microchannel array has been machined with a size deviation of 2μm and surface roughness of 0.2μm.展开更多
Colorectal cancer(CRC)ranks as the third most common cancer globally and the second leading cause of cancer-related deaths,representing a significant health burden.Despite advancements in traditional treatments such a...Colorectal cancer(CRC)ranks as the third most common cancer globally and the second leading cause of cancer-related deaths,representing a significant health burden.Despite advancements in traditional treatments such as surgery,chemotherapy,targeted therapy,and immunotherapy,these approaches still face challenges,including high costs,limited efficacy,and drug resistance.Drug repurposing has emerged as a promising strategy for CRC treatment,offering advantages with reduced development timelines,lower costs,and improved drug accessibility.This review explores drug repurposing strategies for CRC,supported by multidisciplinary technologies,and discusses the current challenges in the field.展开更多
The increasing use of UAV-based LiDAR systems for high-resolution mapping highlights the need for reliable,field-validated accuracy assessment methods.This study presents a practical technique for evaluating geometric...The increasing use of UAV-based LiDAR systems for high-resolution mapping highlights the need for reliable,field-validated accuracy assessment methods.This study presents a practical technique for evaluating geometric and radiometric performance using georeferenced,high-reflectivity foil targets.The method enables precise extraction of target centers and correction of systematic georeferencing errors through 3D transformation.The approach was applied at the Tora Cement Factory in Cairo,Egypt—an industrial site with complex topography—using a DJI Matrice 300 RTK UAV equipped with the Zenmuse L1 LiDAR sensor and Zenmuse P1 photogrammetric camera.Three test flights were performed at altitudes of 50 m(nadir and oblique)and 70 m(oblique),with a high-resolution Structure-from-Motion(SfM)point cloud generated for reference.After transformation,the global RMSE of the LiDAR dataset was reduced to approximately 2.8∼3.2 cm,improving upon the raw uncorrected accuracy of up to 4.6 cm.Surface-wise comparisons showed RMSEs of 3.1 cm on flat areas,3.8 cm on rugged terrain,and 4.5 cm on vertical structures.Additionally,the RGB data embedded in the LiDAR point cloud exhibited a systematic spatial offset between 18 and 43 cm,with an average internal standard deviation near 5 cm,indicating a potential limitation for radiometric applications.The proposed method offers a cost-effective,accurate,and repeatable solution for UAV LiDAR validation and supports operational deployment,quality assurance,and system calibration in real-world scenarios.展开更多
Colon-targeted oral drug delivery systems are one of the most promising therapeutic strategies for alleviating and curing inflammatory bowel disease(IBD),but they still face challenges in successfully passing through ...Colon-targeted oral drug delivery systems are one of the most promising therapeutic strategies for alleviating and curing inflammatory bowel disease(IBD),but they still face challenges in successfully passing through the harsh gastrointestinal environment and intestinal mucus barrier.To overcome the gastrointestinal barriers for oral drug delivery mentioned above,a“spore-like”oral nanodrug delivery platform(Cur/COS/SC NPs)has been developed.Firstly,chitooligosaccharides(COS)are encapsulated on the surface of Curcumin nanoparticles(Cur NPs)to form carrier-free nanoparticles(Cur/COS NPs).Subsequently,inspired by the natural high resistance of spore coat(SC),SC is chosen as the“protective umbrella”to encapsulate Cur/COS NPs for precision targeted therapy of IBD.After oral administration,SC can effectively protect NPs through the rugged gastrointestinal environment and exhibit excellent intestinal mucus penetration characteristics.Moreover,the negatively-charged Cur/COS/SC NPs specifically target positivelycharged inflamed colon via electrostatic interactions.It is demonstrated that Cur/COS/SC NPs can promote the expression of tight junction proteins,inhibit aberrant activation of the Toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-κB(TLR4/MyD88/NF-κB)signaling pathway,and downregulate the levels of pro-inflammatory factors,exhibiting excellent anti-inflammatory effects.Notably,it is found that Cur/COS/SC NPs can significantly increase the richness and diversity of gut microbiota,and restore the homeostasis of gut microbiota by inhibiting pathogenic bacteria and promoting probiotics.Hence,Cur/COS/SC NPs provide a safe,efficient,and feasible new strategy for IBD treatment.展开更多
Augmented reality(AR)is a technology that superimposes digital information onto real-world objects via head-mounted display devices to improve surgical finesse through visually enhanced medical information.With the ra...Augmented reality(AR)is a technology that superimposes digital information onto real-world objects via head-mounted display devices to improve surgical finesse through visually enhanced medical information.With the rapid development of digital technology,AR has been increasingly adopted in orthopedic surgeries across the globe,especially in total knee arthroplasty procedures which demand high precision.By overlaying digital information onto the surgeon's field of view,AR systems enhance precision,improve alignment accuracy,and reduce the risk of complications associated with malalignment.Some concerns have been raised despite accuracy,including the learning curve,long-term outcomes,and technical limitations.Furthermore,it is essential for health practitioners to gain trust in the utilisation of AR.展开更多
The dynamic model of the ball screw mechanism(BSM)in spatial motion,developed in Part I of the study titled‘research and experimental analysis on precision degradation of BSM at low speed’,has been validated through...The dynamic model of the ball screw mechanism(BSM)in spatial motion,developed in Part I of the study titled‘research and experimental analysis on precision degradation of BSM at low speed’,has been validated through a comparison between calculated values and experimentally measured data obtained from a comprehensive ball-screw test bench.In order to study the perform-ance parameters related to the precision degradation characteristics of ball screw under different pre-loads and speeds,the precision degradation test bench for ball screw is set up.Through the experi-ment on the ball-screw comprehensive test bench,the drag torque,stroke deviation,acceleration peak value,axial contact stiffness and other parameters of the BSM under different speeds are ob-tained,and the different preloads are obtained by the drag torque,the changing regularity of which is consistent with the simulation results.A comprehensive analysis of the experimental data reveals that the dynamic characteristics of the ball screw’s spatial motion are significantly influenced by gy-roscopic torque effects.By incorporating these parametric effects,the accuracy degradation charac-teristics of ball screw under different preloads and speeds can be well analyzed.This methodology establishes a technical foundation for investigating ball screw accuracy retention characteristics.展开更多
Multiple myeloma is a complex and challenging blood cancer,particularly in cases where the disease has relapsed or become resistant to treatment.These situations often have a significant impact on both patient surviva...Multiple myeloma is a complex and challenging blood cancer,particularly in cases where the disease has relapsed or become resistant to treatment.These situations often have a significant impact on both patient survival and quality of life.Over recent years,advances in precision medicine and translational medicine have brought about a shift in treatment strategies,moving toward more personalized and targeted approaches.This review highlights the latest developments in the management of refractory and relapsed multiple myeloma,focusing on the current state of precision diagnosis and treatment,the role of translational medicine,and potential future directions in research.By reviewing key studies and clinical trial data,we aim to offer fresh perspectives and strategies that could improve clinical outcomes.展开更多
In this article,we comment paper by Wang et al published recently.The study represents a notable step in the pursuit of precision medicine for inflammatory bowel diseases,offering valuable insights into the potential ...In this article,we comment paper by Wang et al published recently.The study represents a notable step in the pursuit of precision medicine for inflammatory bowel diseases,offering valuable insights into the potential of noninvasive biomarkers for Crohn’s disease(CD)management.This article highlights the significance of the findings,particularly the identification of albumin and fibrinogen amplitude changes as effective,noninvasive biomarkers for predicting endoscopic improvement in CD.The authors introduce a reliable nomogram model,constructed through careful logistic regression analyses,that demonstrates high predictive accuracy across training,internal validation,and external validation cohorts.With further validation through calibration and decision curve analyses,this model shows its clinical relevance and applicability.By incorporating albumin and fibrinogen fluctuations into clinical decision-making,this model addresses a critical gap in noninvasive monitoring tools for CD,offering a practical,patient-centered alternative to guide therapeutic strategies.These findings not only validate the utility of the model but also pave the way for broader integration of biomarker-driven decision-making in the management of CD.This article discusses the broader implications of these advancements,emphasizing their potential to refine patient care and improve outcomes in CD management.展开更多
Organoids are three-dimensional stem cell-derived models that offer a more physiologically relevant representation of tumor biology compared to traditional two-dimensional cell cultures or animal models.Organoids pres...Organoids are three-dimensional stem cell-derived models that offer a more physiologically relevant representation of tumor biology compared to traditional two-dimensional cell cultures or animal models.Organoids preserve the complex tissue architecture and cellular diversity of human cancers,enabling more accurate predictions of tumor growth,metastasis,and drug responses.Integration with microfluidic platforms,such as organ-on-a-chip systems,further enhances the ability to model tumor-environment interactions in real-time.Organoids facilitate in-depth exploration of tumor heterogeneity,molecular mechanisms,and the development of personalized treatment strategies when coupled with multi-omics technologies.Organoids provide a platform for investigating tumor-immune cell interactions,which aid in the design and testing of immune-based therapies and vaccines.Taken together,these features position organoids as a transformative tool in advancing cancer research and precision medicine.展开更多
BACKGROUND Helicobacter pylori(H.pylori)is a Gram-negative bacillus classified as a Group I carcinogen by the World Health Organization.However,the efficacy of eradi-cation therapies has declined in recent years,prima...BACKGROUND Helicobacter pylori(H.pylori)is a Gram-negative bacillus classified as a Group I carcinogen by the World Health Organization.However,the efficacy of eradi-cation therapies has declined in recent years,primarily due to the increasing prevalence of antibiotic resistance.The Maastricht VI/Florence Consensus Report highlights the importance of tailoring treatment strategies to local epidemiological data and individual antimicrobial susceptibility patterns.AIM To investigate the efficacy of precision-guided first-line therapy for H.pylori in-fection using genotypic antibiotic susceptibility testing(G-AST).METHODS This single-center randomized controlled trial enrolled 194 H.pylori-positive patients at a tertiary hospital in Qingdao,China(October 2022-August 2024).Participants were randomized to receive either a 14-day bismuth quadruple therapy(BQT:Amoxicillin,clarithromycin,esomeprazole,and bismuth)or a 14-day G-AST-guided regimen with tailored antibiotics(clarithromycin,levofloxacin,or tetracycline).Treatment efficacy and adverse events were compared between groups using intention-to-treat(ITT)and per-protocol(PP)analyses.Primary and secondary outcomes were analyzed withχ²tests.RESULTS Of 194 patients enrolled,180(92.8%)completed the study as planned.In the ITT analysis,the eradication rate was higher in the G-AST group than in the BQT group[92.8%(95%CI:85.8-96.5)vs 79.4%(95%CI:70.3-86.2),P=0.007],with a risk difference of 13.4%(95%CI:3.7-23.2).In the PP analysis,eradication rates were 97.8%(95%CI:92.4-99.4)in the G-AST group and 84.1%(95%CI:75.1-90.3)in the BQT group(P=0.001),with a risk difference of 13.7%(95%CI:5.5-23.0).Adverse event incidence did not differ significantly between groups(30.9%vs 28.9%,P=0.754).CONCLUSION G-AST-guided therapy yielded higher eradication rates than empirical BQT in first-line H.pylori treatment without increasing adverse events,supporting the clinical utility of individualized,resistance-based therapy.展开更多
This paper highlights the innovative approach and findings of the recently published study by Xu et al,which underscores the integration of radiomics and clinicoradiological factors to enhance the preoperative predict...This paper highlights the innovative approach and findings of the recently published study by Xu et al,which underscores the integration of radiomics and clinicoradiological factors to enhance the preoperative prediction of microvascular invasion in patients with hepatitis B virus-related hepatocellular carcinoma(HBV-HCC).The study’s use of contrast-enhanced computed tomography radiomics to construct predictive models offers a significant advancement in the surgical planning and management of HBV-HCC,potentially transforming patient outcomes through more personalized treatment strategies.This editorial commends the study's contribution to precision medicine and discusses its implic-ations for future research and clinical practice.展开更多
文摘In the dynamic landscape of modern healthcare and precision medicine,the digital revolution is reshaping medical industries at an unprecedented pace,and traditional Chinese medicine(TCM)is no exception[1-4].The paper“From digits towards digitization:the past,present,and future of traditional Chinese medicine”by Academician&TCM National Master Qi WANG(王琦).
基金supported by grants from the Natural Science Foundation of Shandong Province(Grant No.ZR2024QH058).
文摘In the era of precision medicine,the breast cancer surgical treatment field is gradually moving toward a de-escalation model.Through precise preoperative assessments and multidisciplinary decision-making,surgical trauma can be decreased,and patients’quality of life can be improved by ensuring safety.Herein,we explore the axillary de-escalation surgery model for breast cancer.
文摘Lynch syndrome(LS)is the most common hereditary colorectal cancer(CRC)predisposition syndrome,characterized by a high mutational burden and microsatellite instability-high(MSI-H)tumors.Immunology of LS-associated CRC(LS-CRC)is unique,with significant implications for treatment.Despite well-established knowledge of LS immunology,immunotherapy dose and treatment response can vary significantly based on local tumor immunity and specific germline pathogenic variant of LS genes.This variability necessitates tailored surveillance strategies and new personalised immunotherapy approaches for LS patients.LS-CRC often benefits from immunotherapy due to the distinct tumor microenvironment(TME)and the variety of tumor infiltrating lymphocytes(TILs).This perspective discusses a novel approach of analysing spatial TILs at a single-cell level using tumor whole slide images(WSIs)that accounts for the distinct TME of LS-CRC.By emphasizing the necessity of personalized medicine in hereditary cancer syndromes,the future research and clinical practices that enhance patient outcomes through precision oncology is inspired.
基金supported by grants from the National Natural Science Foundation of China(Grant Nos.82103614 and 32171363)Natural Science Foundation of Fujian Province of China(Grant No.2021J05007)+4 种基金funding from the start-up fund for Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast CancerXiamen’s Key Laboratory of Precision Medicine for Endocrine-Related Cancersstart-up and supporting funds from the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital for Guo-Jun Zhang and Jing-Wen BaiKey Research and development program for social development of Yunnan Science and Technology Department(Grant No.202403AC100014-2)horizontal project funding from the Third Affiliated Hospital of Kunming Medical University(Grant Nos.20233160A0866 and 20243160A0511)。
文摘The management of breast cancer,one of the most common and heterogeneous malignancies,has transformed with the advent of precision medicine.This review explores current developments in genetic profiling,molecular diagnostics,and targeted therapies that have revolutionized breast cancer treatment.Key innovations,such as cyclin-dependent kinases 4/6(CDK4/6)inhibitors,antibodydrug conjugates(ADCs),and immune checkpoint inhibitors(ICIs),have improved outcomes for hormone receptor-positive(HR+),HER2-positive(HER2+),and triple-negative breast cancer(TNBC)subtypes remarkably.Additionally,emerging treatments,such as PI3K inhibitors,poly(ADP-ribose)polymerase(PARP)inhibitors,and m RNA-based therapies,offer new avenues for targeting specific genetic mutations and improving treatment response,particularly in difficult-to-treat breast cancer subtypes.The integration of liquid biopsy technologies provides a non-invasive approach for real-time monitoring of tumor evolution and treatment response,thus enabling dynamic adjustments to therapy.Molecular imaging and artificial intelligence(AI)are increasingly crucial in enhancing diagnostic precision,personalizing treatment plans,and predicting therapeutic outcomes.As precision medicine continues to evolve,it has the potential to significantly improve survival rates,decrease recurrence,and enhance quality of life for patients with breast cancer.By combining cutting-edge diagnostics,personalized therapies,and emerging treatments,precision medicine can transform breast cancer care by offering more effective,individualized,and less invasive treatment options.
基金Supported by the Natural Science Foundation of Jilin Province,No.YDZJ202401182ZYTSJilin Provincial Key Laboratory of Precision Infectious Diseases,No.20200601011JCJilin Provincial Engineering Laboratory of Precision Prevention and Control for Common Diseases,Jilin Province Development and Reform Commission,No.2022C036.
文摘Artificial intelligence(AI)is driving a paradigm shift in gastroenterology and hepa-tology by delivering cutting-edge tools for disease screening,diagnosis,treatment,and prognostic management.Through deep learning,radiomics,and multimodal data integration,AI has achieved diagnostic parity with expert cli-nicians in endoscopic image analysis(e.g.,early gastric cancer detection,colorectal polyp identification)and non-invasive assessment of liver pathologies(e.g.,fibrosis staging,fatty liver typing)while demonstrating utility in personalized care scenarios such as predicting hepatocellular carcinoma recurrence and opti-mizing inflammatory bowel disease treatment responses.Despite these advance-ments challenges persist including limited model generalization due to frag-mented datasets,algorithmic limitations in rare conditions(e.g.,pediatric liver diseases)caused by insufficient training data,and unresolved ethical issues related to bias,accountability,and patient privacy.Mitigation strategies involve constructing standardized multicenter databases,validating AI tools through prospective trials,leveraging federated learning to address data scarcity,and de-veloping interpretable systems(e.g.,attention heatmap visualization)to enhance clinical trust.Integrating generative AI,digital twin technologies,and establishing unified ethical/regulatory frameworks will accelerate AI adoption in primary care and foster equitable healthcare access while interdisciplinary collaboration and evidence-based implementation remain critical for realizing AI’s potential to redefine precision care for digestive disorders,improve global health outcomes,and reshape healthcare equity.
基金Projects(U22B2084,52275483,52075142)supported by the National Natural Science Foundation of ChinaProject(2023ZY01050)supported by the Ministry of Industry and Information Technology High Quality Development,China。
文摘The gears of new energy vehicles are required to withstand higher rotational speeds and greater loads,which puts forward higher precision essentials for gear manufacturing.However,machining process parameters can cause changes in cutting force/heat,resulting in affecting gear machining precision.Therefore,this paper studies the effect of different process parameters on gear machining precision.A multi-objective optimization model is established for the relationship between process parameters and tooth surface deviations,tooth profile deviations,and tooth lead deviations through the cutting speed,feed rate,and cutting depth of the worm wheel gear grinding machine.The response surface method(RSM)is used for experimental design,and the corresponding experimental results and optimal process parameters are obtained.Subsequently,gray relational analysis-principal component analysis(GRA-PCA),particle swarm optimization(PSO),and genetic algorithm-particle swarm optimization(GA-PSO)methods are used to analyze the experimental results and obtain different optimal process parameters.The results show that optimal process parameters obtained by the GRA-PCA,PSO,and GA-PSO methods improve the gear machining precision.Moreover,the gear machining precision obtained by GA-PSO is superior to other methods.
基金funded by the Tianfu Emei Plan(a talent program of Sichuan Province,China),awarded to Huilian Che。
文摘Approximately 2.5%of the global population experience allergic reactions to seafood,making it one of the most prevalent and life-threatening allergies.Seafood allergy can lead to the disruption of the intestinal barrier,possibly due to aberrant intestinal glycosylation.In this study,the mechanisms underlying seafood allergy were explored through the lens of intestinal glycobiology.Mice were sensitized with tropomyosin,resulting in significant increases in allergy symptom scores,specific antibody and T helper 2 cytokine levels.Intestinal damage was confirmed by histopathology,as well as by assessments and levels of diamine oxidase and claudin-1.Moreover,alterations in glycosylated proteins within the jejunum were analyzed using highthroughput mass spectrometry and the pGlyco3.0 search engine.Precision N-glycoproteomics analysis yielded 2283 glycosylation peptides corresponding to 655 unique glycosylation sites on 399 proteins.Differential expression and enrichment analyses revealed that differentially expressed glycoproteins were significantly enriched in the extracellular matrix(ECM)-receptor interaction pathway and focal adhesion pathway.In conclusion,tropomyosin sensitization leads to intestinal glycome changes,accompanied by remodeling of the intestinal ECM.Our research establishes an essential theoretical basis for targeting the intestinal glycome and ECM remodeling in a precise and fine-tuned manner for the treatment of food allergies.
文摘Background:Precision medicine(PM)has taken center stage in healthcare since the completion of the genomic project.Developed countries have gradually integrated PM into mainstream patient management.However,Nigeria still grapples with wide acceptance,key translational research and implementation of PM.This study sought to explore the knowledge and attitude of PM among pharmacists as key stakeholders in the healthcare team.Methods:A cross‐sectional study was conducted in selected tertiary hospitals across the country.A 21‐item semi‐structured questionnaire was administered by hybrid online and physical methods and the results analyzed with Statistical Package for the Social Sciences Version 25.Descriptive statistics were used to summarize the data.A chi‐square test was employed to determine the association of knowledge of PM and the sociodemographic characteristics of the study population.Results:A total of 167 hospital pharmacists participated in the study.A high proportion of the participants are familiar with artificial intelligence(91.75%),Pharmacogenomics(84.5%),and precision medicine(61%).Overall,38.9%of the pharmacists had a good knowledge while 13.2%had a poor knowledge of PM and associated terms.The level of knowledge did not correlate significantly with gender(X^(2)=3.21,p=0.201),age(X^(2)=5,p=0.27),marital status(X^(2)=3.21,p=0.201),and professional level(X^(2)=6.85,p=0.144).The most important value of precision medicine to hospital pharmacists is the ability to minimize the impact of disease through preventive medicine(49%)while a large portion are pursuing and or actively planning to pursue additional education in precision medicine.Conclusions:There is a highly positive attitude toward the prospect of PM among hospital pharmacists in Nigeria.Education modules in this field are highly recommended as most do not have a holistic knowledge of terms used in PM.Also,more research aimed at translating PM knowledge into clinical practice is recommended.
文摘Pancreatic ductal adenocarcinoma(PDAC)is a global health challenge and remains one of the most lethal malignancies;there are only a few therapeutic options.However,significant efforts have led to the identification of major genetic factors that drive the progression and pathogenesis of PDAC.Notably,the research and application of molecular targeted therapies and immunotherapies have rapidly increased and facilitated great progress in the treatment of many malignant tumors,additional targeted therapies and immunotherapy based on next-generation sequencing results provide new opportunities for the diagnosis and treatment of pancreatic tumors.Immune checkpoint inhibitors are also now being incorporated as PDAC therapies,and combinations of molecularly targeted therapies with immunotherapies are emerging as strategies for boosting the immune response.The investigation of biomarkers of a response or primary resistance to immunotherapies is also an emerging research area.Herein,we further discuss the recent technological advances that continue to expand our understanding of PDAC complexity.We discuss the advancements expected in the near future,including biomarker-driven treatments and immunotherapies.We presume that the clinical translation of these research efforts will improve the survival outcomes of this challenging disease,which are currently dismal.
基金co-supported by the Enterprise Innovation and Development Joint Program of the National Natural Science Foundation of China(No.U20B2032)Open Project Funding of State Key Laboratory for High Performance Tools(GXNGJSKL-2024-08)+1 种基金Open Foundation of the State Key Laboratory of Intelligent Manufacturing Equipment and Technology(IMETKF2023005)Introduced Innovative Scientific Research Team Project of Zhongshan(the tenth batch)(CXTD2023008)。
文摘Micro-grinding has been widely used in aerospace and other industry.However,the small diameter of the micro-grinding tool has limited its machining performance and efficiency.In order to solve the above problems,micro-structure has been applied on the micro-grinding tool.A morphology modeling has been established in this study to characterize the surface of microstructured micro-grinding tool,and the grinding performance of micro-structured micro-grinding tool has been analyzed through undeformed chip thickness,abrasive edge width,and effective distance between abrasives.Then deviation analysis,path optimization and parameter optimization of microchannel array precision grinding have been finished to improve processing quality and efficiency,and the deflection angle has the most obvious effects on the rectangular slot depth,micro-structured micro-grinding tool could reduce 10%surface roughness and 20%grinding force compared to original micro-grinding tool.Finally,the microchannel array has been machined with a size deviation of 2μm and surface roughness of 0.2μm.
基金Supported by the National Natural Science Foundation of China,No.82273457the Natural Science Foundation of Guangdong Province,No.2023A1515012762Science and Technology Special Project of Guangdong Province,No.210715216902829.
文摘Colorectal cancer(CRC)ranks as the third most common cancer globally and the second leading cause of cancer-related deaths,representing a significant health burden.Despite advancements in traditional treatments such as surgery,chemotherapy,targeted therapy,and immunotherapy,these approaches still face challenges,including high costs,limited efficacy,and drug resistance.Drug repurposing has emerged as a promising strategy for CRC treatment,offering advantages with reduced development timelines,lower costs,and improved drug accessibility.This review explores drug repurposing strategies for CRC,supported by multidisciplinary technologies,and discusses the current challenges in the field.
文摘The increasing use of UAV-based LiDAR systems for high-resolution mapping highlights the need for reliable,field-validated accuracy assessment methods.This study presents a practical technique for evaluating geometric and radiometric performance using georeferenced,high-reflectivity foil targets.The method enables precise extraction of target centers and correction of systematic georeferencing errors through 3D transformation.The approach was applied at the Tora Cement Factory in Cairo,Egypt—an industrial site with complex topography—using a DJI Matrice 300 RTK UAV equipped with the Zenmuse L1 LiDAR sensor and Zenmuse P1 photogrammetric camera.Three test flights were performed at altitudes of 50 m(nadir and oblique)and 70 m(oblique),with a high-resolution Structure-from-Motion(SfM)point cloud generated for reference.After transformation,the global RMSE of the LiDAR dataset was reduced to approximately 2.8∼3.2 cm,improving upon the raw uncorrected accuracy of up to 4.6 cm.Surface-wise comparisons showed RMSEs of 3.1 cm on flat areas,3.8 cm on rugged terrain,and 4.5 cm on vertical structures.Additionally,the RGB data embedded in the LiDAR point cloud exhibited a systematic spatial offset between 18 and 43 cm,with an average internal standard deviation near 5 cm,indicating a potential limitation for radiometric applications.The proposed method offers a cost-effective,accurate,and repeatable solution for UAV LiDAR validation and supports operational deployment,quality assurance,and system calibration in real-world scenarios.
基金supported by the National Natural Science Foundation of China(Nos.82272847,82304417,82303529,82171333)China Postdoctoral Science Foundation(Nos.2023TQ0307,2023M743231,2023M730971)+2 种基金Science and Technology Project of Henan Province(No.242102311204)Postdoctoral Fellowship Program of CPSF(No.GZB20230675)Modern Analysis and Computer Center of Zhengzhou University.
文摘Colon-targeted oral drug delivery systems are one of the most promising therapeutic strategies for alleviating and curing inflammatory bowel disease(IBD),but they still face challenges in successfully passing through the harsh gastrointestinal environment and intestinal mucus barrier.To overcome the gastrointestinal barriers for oral drug delivery mentioned above,a“spore-like”oral nanodrug delivery platform(Cur/COS/SC NPs)has been developed.Firstly,chitooligosaccharides(COS)are encapsulated on the surface of Curcumin nanoparticles(Cur NPs)to form carrier-free nanoparticles(Cur/COS NPs).Subsequently,inspired by the natural high resistance of spore coat(SC),SC is chosen as the“protective umbrella”to encapsulate Cur/COS NPs for precision targeted therapy of IBD.After oral administration,SC can effectively protect NPs through the rugged gastrointestinal environment and exhibit excellent intestinal mucus penetration characteristics.Moreover,the negatively-charged Cur/COS/SC NPs specifically target positivelycharged inflamed colon via electrostatic interactions.It is demonstrated that Cur/COS/SC NPs can promote the expression of tight junction proteins,inhibit aberrant activation of the Toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-κB(TLR4/MyD88/NF-κB)signaling pathway,and downregulate the levels of pro-inflammatory factors,exhibiting excellent anti-inflammatory effects.Notably,it is found that Cur/COS/SC NPs can significantly increase the richness and diversity of gut microbiota,and restore the homeostasis of gut microbiota by inhibiting pathogenic bacteria and promoting probiotics.Hence,Cur/COS/SC NPs provide a safe,efficient,and feasible new strategy for IBD treatment.
基金Supported by The Hunan Provincial Natural Science Foundation of China,No.2023JJ30773,No.2025JJ60480,and No.2025JJ60552The Scientific Research Program of The Hunan Provincial Health Commission,No.202204072544+4 种基金The Science and Technology Innovation Program of Hunan Province,No.2024RC3053The CBT ECR/MCR Scheme,No.324910-0028/07National Natural Science Foundation of China,No.32300652The Scientific Research Program of Hunan Provincial Health Commission,No.W20243023The Scientific Research Launch Project for New Employees of The Second Xiangya Hospital of Central South University.
文摘Augmented reality(AR)is a technology that superimposes digital information onto real-world objects via head-mounted display devices to improve surgical finesse through visually enhanced medical information.With the rapid development of digital technology,AR has been increasingly adopted in orthopedic surgeries across the globe,especially in total knee arthroplasty procedures which demand high precision.By overlaying digital information onto the surgeon's field of view,AR systems enhance precision,improve alignment accuracy,and reduce the risk of complications associated with malalignment.Some concerns have been raised despite accuracy,including the learning curve,long-term outcomes,and technical limitations.Furthermore,it is essential for health practitioners to gain trust in the utilisation of AR.
基金Supported by the National Natural Science Foundation of China(No.51575014,51505020)the Key Foundation Project of China Academy of Railway Sciences(No.2021YJ200).
文摘The dynamic model of the ball screw mechanism(BSM)in spatial motion,developed in Part I of the study titled‘research and experimental analysis on precision degradation of BSM at low speed’,has been validated through a comparison between calculated values and experimentally measured data obtained from a comprehensive ball-screw test bench.In order to study the perform-ance parameters related to the precision degradation characteristics of ball screw under different pre-loads and speeds,the precision degradation test bench for ball screw is set up.Through the experi-ment on the ball-screw comprehensive test bench,the drag torque,stroke deviation,acceleration peak value,axial contact stiffness and other parameters of the BSM under different speeds are ob-tained,and the different preloads are obtained by the drag torque,the changing regularity of which is consistent with the simulation results.A comprehensive analysis of the experimental data reveals that the dynamic characteristics of the ball screw’s spatial motion are significantly influenced by gy-roscopic torque effects.By incorporating these parametric effects,the accuracy degradation charac-teristics of ball screw under different preloads and speeds can be well analyzed.This methodology establishes a technical foundation for investigating ball screw accuracy retention characteristics.
基金supported by grants from the 925th Science Foundation(Grant Nos.2023-3 and 2024-2/3).
文摘Multiple myeloma is a complex and challenging blood cancer,particularly in cases where the disease has relapsed or become resistant to treatment.These situations often have a significant impact on both patient survival and quality of life.Over recent years,advances in precision medicine and translational medicine have brought about a shift in treatment strategies,moving toward more personalized and targeted approaches.This review highlights the latest developments in the management of refractory and relapsed multiple myeloma,focusing on the current state of precision diagnosis and treatment,the role of translational medicine,and potential future directions in research.By reviewing key studies and clinical trial data,we aim to offer fresh perspectives and strategies that could improve clinical outcomes.
文摘In this article,we comment paper by Wang et al published recently.The study represents a notable step in the pursuit of precision medicine for inflammatory bowel diseases,offering valuable insights into the potential of noninvasive biomarkers for Crohn’s disease(CD)management.This article highlights the significance of the findings,particularly the identification of albumin and fibrinogen amplitude changes as effective,noninvasive biomarkers for predicting endoscopic improvement in CD.The authors introduce a reliable nomogram model,constructed through careful logistic regression analyses,that demonstrates high predictive accuracy across training,internal validation,and external validation cohorts.With further validation through calibration and decision curve analyses,this model shows its clinical relevance and applicability.By incorporating albumin and fibrinogen fluctuations into clinical decision-making,this model addresses a critical gap in noninvasive monitoring tools for CD,offering a practical,patient-centered alternative to guide therapeutic strategies.These findings not only validate the utility of the model but also pave the way for broader integration of biomarker-driven decision-making in the management of CD.This article discusses the broader implications of these advancements,emphasizing their potential to refine patient care and improve outcomes in CD management.
基金supported by the Chinese Academy of Medical Sciences(Grant No.2021RU002)Beijing Natural Science Foundation(Grant No.Z240013)+2 种基金National Natural Science Foundation of China(Grant Nos.82450111,82388102,82373416,and 92259303)Beijing Research Ward Excellence Program(Grant Nos.BRWEP2024W034080200 and BRWEP2024W034080204)Peking University People’s Hospital Research and Development Funds(Grant No.RZG2024-02).
文摘Organoids are three-dimensional stem cell-derived models that offer a more physiologically relevant representation of tumor biology compared to traditional two-dimensional cell cultures or animal models.Organoids preserve the complex tissue architecture and cellular diversity of human cancers,enabling more accurate predictions of tumor growth,metastasis,and drug responses.Integration with microfluidic platforms,such as organ-on-a-chip systems,further enhances the ability to model tumor-environment interactions in real-time.Organoids facilitate in-depth exploration of tumor heterogeneity,molecular mechanisms,and the development of personalized treatment strategies when coupled with multi-omics technologies.Organoids provide a platform for investigating tumor-immune cell interactions,which aid in the design and testing of immune-based therapies and vaccines.Taken together,these features position organoids as a transformative tool in advancing cancer research and precision medicine.
基金Supported by Qilu Health Outstanding Young Talent Cultivation Project,No.QDFY-3839.
文摘BACKGROUND Helicobacter pylori(H.pylori)is a Gram-negative bacillus classified as a Group I carcinogen by the World Health Organization.However,the efficacy of eradi-cation therapies has declined in recent years,primarily due to the increasing prevalence of antibiotic resistance.The Maastricht VI/Florence Consensus Report highlights the importance of tailoring treatment strategies to local epidemiological data and individual antimicrobial susceptibility patterns.AIM To investigate the efficacy of precision-guided first-line therapy for H.pylori in-fection using genotypic antibiotic susceptibility testing(G-AST).METHODS This single-center randomized controlled trial enrolled 194 H.pylori-positive patients at a tertiary hospital in Qingdao,China(October 2022-August 2024).Participants were randomized to receive either a 14-day bismuth quadruple therapy(BQT:Amoxicillin,clarithromycin,esomeprazole,and bismuth)or a 14-day G-AST-guided regimen with tailored antibiotics(clarithromycin,levofloxacin,or tetracycline).Treatment efficacy and adverse events were compared between groups using intention-to-treat(ITT)and per-protocol(PP)analyses.Primary and secondary outcomes were analyzed withχ²tests.RESULTS Of 194 patients enrolled,180(92.8%)completed the study as planned.In the ITT analysis,the eradication rate was higher in the G-AST group than in the BQT group[92.8%(95%CI:85.8-96.5)vs 79.4%(95%CI:70.3-86.2),P=0.007],with a risk difference of 13.4%(95%CI:3.7-23.2).In the PP analysis,eradication rates were 97.8%(95%CI:92.4-99.4)in the G-AST group and 84.1%(95%CI:75.1-90.3)in the BQT group(P=0.001),with a risk difference of 13.7%(95%CI:5.5-23.0).Adverse event incidence did not differ significantly between groups(30.9%vs 28.9%,P=0.754).CONCLUSION G-AST-guided therapy yielded higher eradication rates than empirical BQT in first-line H.pylori treatment without increasing adverse events,supporting the clinical utility of individualized,resistance-based therapy.
基金Supported by Shandong Province Medical and Health Science and Technology Development Plan Project,No.202203030713Science and Technology Program of Yantai Affiliated Hospital of Binzhou Medical University,No.YTFY2022KYQD06。
文摘This paper highlights the innovative approach and findings of the recently published study by Xu et al,which underscores the integration of radiomics and clinicoradiological factors to enhance the preoperative prediction of microvascular invasion in patients with hepatitis B virus-related hepatocellular carcinoma(HBV-HCC).The study’s use of contrast-enhanced computed tomography radiomics to construct predictive models offers a significant advancement in the surgical planning and management of HBV-HCC,potentially transforming patient outcomes through more personalized treatment strategies.This editorial commends the study's contribution to precision medicine and discusses its implic-ations for future research and clinical practice.
